0000899243-15-003640.txt : 20150820 0000899243-15-003640.hdr.sgml : 20150820 20150820132521 ACCESSION NUMBER: 0000899243-15-003640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150818 FILED AS OF DATE: 20150820 DATE AS OF CHANGE: 20150820 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Williams Michael J PhD CENTRAL INDEX KEY: 0001377232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 151065939 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES, INC. STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 FORMER NAME: FORMER CONFORMED NAME: Williams Michael J DATE OF NAME CHANGE: 20061003 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-18 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001377232 Williams Michael J PhD ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Executive Vice President Common Stock 2015-08-18 4 M 0 6586 26.66 A 36672 D Common Stock 2015-08-18 4 S 0 6586 78.34 D 30086 D Common Stock 2015-08-18 4 M 0 3750 26.66 A 33836 D Common Stock 2015-08-18 4 M 0 5818 17.19 A 39654 D Non-Qualified Stock Option (Right to buy) 26.66 2015-08-18 4 M 0 6586 0.00 D 2017-02-13 Common Stock 6586 0 D Incentive Stock Option (Right to buy) 26.66 2015-08-18 4 M 0 3750 0.00 D 2017-02-13 Common Stock 3750 0 D Incentive Stock Option (Right to buy) 17.19 2015-08-18 4 M 0 5818 0.00 D 2016-02-13 Common Stock 5818 0 D The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $78.33 to $78.40, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. Grant of option to buy shares of IDEXX Laboratories Inc. common stock that became exercisable as to 3,834 shares on 2/14/2011, 2/14/2012, 2/14/2013 and 2/14/2014 and the remaining 1,959 shares on 2/14/2015, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Grant of option to buy 1,875 shares of IDEXX Laboratories, Inc. common stock that became exercisable on the fifth anniversary date (2/14/2015) of the date of grant, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 1 share on 02/14/2010 and 02/14/2013 and the remaining 2,909 shares on 02/14/2014, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. /s/ Lily J. Lu, Attorney-in-Fact for Michael J. Williams, PhD 2015-08-20